Arrowhead Pharmaceuticals Inc annual net income for fiscal TTM was -$320 million, a decrease of 15,900.0% from -$2 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | TTM → 2026-06-30 | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 | 2013-09-30 | 2012-09-30 | 2011-09-30 | 2010-09-30 | 2009-09-30 | 2008-09-30 | 2007-09-30 | 2006-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | ($320M) | ($2M) | ($599M) | ($205M) | ($176M) | ($141M) | ($85M) | $68M | ($54M) | ($34M) | ($82M) | ($92M) | ($59M) | ($31M) | ($21M) | ($3M) | ($6M) | ($19M) | ($27M) | ($30M) | ($19M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | ($194M) | ($133M) | $31M | ($24M) | ($175M) | $370M | ($173M) | ($171M) | ($171M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ARWR metrics: Revenue · Gross Profit · Operating Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All ARWR financial statements → Interactive ARWR charts →
About TickerBase · Data methodology & sources · Privacy · Terms